• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Adare Pharma Solutions Opens New Small-Scale Lab

    Stevanato Group Launches After-sales Service Offering

    X-Chem Acquires IntelliSyn and AviSyn

    Aphena’s $21M Cookeville Expansion Nears Completion

    BioMed X, Janssen Enter Oral Drug Delivery Alliance
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Aphena’s $21M Cookeville Expansion Nears Completion

    PromoCell Receives EXCiPACT Certification

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    Humanigen, Emergent Enter Covid-19 Partnership

    Samsung Bioepis Opens New Headquarters
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    The State of Clinical Trial Technology

    Adare Pharma Solutions Opens New Small-Scale Lab

    The Future of Clinical Trials Series: Part II

    X-Chem Acquires IntelliSyn and AviSyn

    Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    PCI Pharma Services

    Emergent BioSolutions

    Cytovance Biologics

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Syngene

    Baxter BioPharma Solutions

    PCI Pharma Services

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    New York City is Not Dead, Our Life Sciences Sector is Thriving

    Amid the COVID-19 pandemic, life sciences is booming in NYC!

    New York City is Not Dead, Our Life Sciences Sector is Thriving
    Related CONTENT
    • 20th Annual Contracting & Outsourcing Conference & Exhibition
    • Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    • Virtual Clinical Trials: The Future of Dermatology Studies
    • Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
    • Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Sara Jane Demy, CEO & Founder, Demy-Colton10.01.20
    As a born and bred New Yorker, I was disheartened when I read the New York Post op-ed by James Altucher, “NYC is dead forever – here’s why.” I’ve lived in the city for over 40 years, and most of my adult life. Since the start of the COVID-19 pandemic in March, I have remained in the city and decided not to leave, despite living in close proximity to all of the east-side hospitals located between 14th and 34th Streets. It was heartbreaking to drive along the FDR Drive, and see the number of refrigerated morgue trucks grow in number almost daily. There was a palpable air of dread and fear during those darkest months, as New York City struggled to get the pandemic under control.
     
    Fast forward to now. We have been able to “flatten the curve” in our city, thanks to people following public health guidelines by wearing masks and social distancing. New Yorkers witnessed the horror of this uncontrolled virus first-hand and understood the foe they were up against. And we rose to the occasion.
     
    As a networker and connector in the life sciences industry, I built my career around bringing people together to solve problems, form collaborations and advance this industry at in-person events. When the pandemic first hit, it was an extremely dark and difficult time for me, because our team was about to launch a new international investor and business development conference in New York City, called BioFuture, which was to have taken place in April at the Lotte Palace Hotel in Midtown.
     
    As CEO and Founder of Demy-Colton, a company dedicated to facilitating growth and advancement in life sciences and digital medicine, through the creation of specialized industry conferences and events - my whole career has been dedicated to connecting entrepreneurs and companies focused on developing innovative new therapies to improve patient lives and care. Now that meeting in person was impossible, what could we do to continue our mission? I saw my whole company, and everything I’ve built flash before my eyes, and really wondered how we could adapt to this “new normal.”
     
    Prior to founding Demy-Colton in 2008, I was Vice President for Business Development and Investor Relations at the Biotechnology Innovation Organization (BIO). I also spent more than a decade as a Director for Foreign Investment at the Empire State Development Corporation, which is where I was initially introduced to the pharma and biotech community. In fact, the first person to head up New York’s biotechnology association, NYBio, was introduced at a global biotech event that I organized many years ago!
     
    So, you can say that I’ve watched the New York City life sciences community transition over the last few decades from being a major global research center to becoming a burgeoning life science and digital medicine hub as well. It has only been in the last decade that NYC’s strength in life sciences has come into sharper focus - and it is long overdue.
     
    For the last few years I’ve watched New York welcome innovative life sciences, medical device and digital health companies from all over the world. New York City and the Empire State have now grown to be one of the largest biotech hubs in the United States, and one of the biggest on the East Coast, second to Boston.
     
    In 2016, New York Gov. Andrew Cuomo announced a $650M initiative to spur the growth of a new, world-class life science cluster in New York. Last September, NYCEDC and Deerfield Management announced a partnership to create a life science campus – MATTER to create LifeSci NYC’s newest incubator.
     
    Demand for life sciences space in New York City, which houses 60% of the country's pharmaceutical industry, is flourishing amid the pandemic, with funding and deal flow continuing well into the second quarter, according to a recent CBRE report. New York City’s life sciences sector continues to thrive in an otherwise challenging time for traditional office tenants, according to the report. Lab tenants are continuing to expand in the wake of the COVID-19 pandemic, in response to ongoing momentum and a robust flow of financing by venture capital and NIH funding sources.
     
    I watched as the Alexandria Center for Life Science grew over the years to what is now a sprawling, 728,000-square-foot campus by the East River in Kips Bay. Alexandria leased nearly 20,000 square feet in April to BlueRock Therapeutics, a billion-dollar cell therapy company that was purchased by Bayer in August. 
     
    What is also amazing about New York City is our unrelenting commitment to diversity. Demy-Colton is a fierce advocate for diversity in all forms and has made a commitment to fostering inclusion in all of our events, both in-person and virtual. As the founder of Biotech Showcase, I led the movement on calling out “manels,” and made a commitment to ensure gender diversity on all panels, at all events.
     
    Recently, we launched a new virtual events initiative, the Virtual Salon Series, which has been complimentary for anyone working in the life sciences or digital health industries. We’ve featured cutting-edge science, with topics ranging from gene editing to our most recent panel, the Futurescaping of Oncology. Our Fireside Chat series will feature Mike Gaito, the Global Head of Healthcare Banking, Amy Abernethy, Principal Deputy Commissioner of the U.S. Food and Drug Administration, and many others.
     
    I received many comments from C-level executives, scientists, researchers and investors in our industry, stressing the importance of “connecting” with each other during this unprecedented time. They seemed to truly appreciate our newly launched Virtual Salon Series, and the opportunity for continued dialogue.
     
    I love this city, and will continue to make connections, foster inclusion, and promote interesting new startups from the city, and across the world.
     
    And no -- New York is not dead. We are just beginning.
     


    Sara Demy is one of the most influential networkers and connectors in the life sciences industry. As the CEO & Founder of Demy-Colton, a leading life sciences events organizer, she brings more than 22 years of experience launching, developing, and shaping high-profile investor and business development conferences in the healthcare industry.
    Related Searches
    • Drug Development
    Suggested For You
    20th Annual Contracting & Outsourcing Conference & Exhibition 20th Annual Contracting & Outsourcing Conference & Exhibition
    Civica to Build an Essential Medicines Manufacturing Facility in Virginia Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Virtual Clinical Trials: The Future of Dermatology Studies Virtual Clinical Trials: The Future of Dermatology Studies
    Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Advancing Digital Endpoints in Clinical Trials Advancing Digital Endpoints in Clinical Trials
    Navigating Uncertainty: Considerations for Life Sciences 2021 Navigating Uncertainty: Considerations for Life Sciences 2021
    Tjoapack Invests $12.1M in Packaging & Supply Chain Facility Tjoapack Invests $12.1M in Packaging & Supply Chain Facility
    CDMO Stelis Continues Expansion CDMO Stelis Continues Expansion
    Legacy Pharma Solutions Legacy Pharma Solutions
    Life Science Success Podcast: Matt Hicks Life Science Success Podcast: Matt Hicks
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Lonza and Be The Match BioTherapies Enter CGT Partnership Lonza and Be The Match BioTherapies Enter CGT Partnership
    Inspecting the Unexpected Inspecting the Unexpected

    Related Expert's Opinion

    • Clinical Trials | Drug Development | Information Technology
      Virtual Clinical Trials: The Future of Dermatology Studies

      Virtual Clinical Trials: The Future of Dermatology Studies

      COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.
      Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21

    • Clinical Trials | Drug Development
      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.
      Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21

    • Drug Development | Industry News | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21


    • Clinical Trials | Drug Development | Information Technology
      Advances in Intelligent Automation

      Advances in Intelligent Automation

      The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.
      Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20

    • Drug Development
      Navigating Uncertainty: Considerations for Life Sciences 2021

      Navigating Uncertainty: Considerations for Life Sciences 2021

      With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.
      Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20

    • Clinical Trials | Drug Development
      How to Balance Internal and External Staff Within Outsourcing Models

      How to Balance Internal and External Staff Within Outsourcing Models

      Strategies to consider in flexed staffing models.
      John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20


    • Biologics, Proteins, Vaccines | Drug Development
      The Importance of Global Collaboration in the Fight Against COVID-19

      The Importance of Global Collaboration in the Fight Against COVID-19

      Industry continues to join forces to find new treatments for COVID-19.
      Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20

    • Clinical Trials | Drug Development
      FDA Response to COVID-19

      FDA Response to COVID-19

      A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
      Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20

    • Clinical Trials | Drug Development
      Beyond 2020: The Future of CROs

      Beyond 2020: The Future of CROs

      How will remote site access impact the CRO business?
      Ryan Jones, CEO, Florence Healthcare 08.21.20


    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      New models from CROs are enabling further biotech expansion
      Davide Garrisi, Biotech Portfolio Lead, PPD Biotech 08.20.20

    • Clinical Trials | Drug Development
      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Evaluating outsourcing strategies amid a complex trial landscape to further enhance clinical operations.
      Michael D. Jones , Vice President of Clinical FSP Client Engagement, IQVIA 08.17.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Tackling Analytical Challenges in Gene Therapy

      Tackling Analytical Challenges in Gene Therapy

      Key considerations on how to navigate the field as a gene therapy developer.
      Khanh Ngo Courtney, Ph.D., Biologics Project Director, Avomeen 07.17.20


    • Drug Development | GMPs/GCPs | Information Technology | QA/QC
      Solving Compliance Challenges and Beyond with Natural Language Processing

      Solving Compliance Challenges and Beyond with Natural Language Processing

      Understanding new data sources and elevating compliance to drive innovation.
      Updesh Dosanjh, Practice Lead, IQVIA Vigilance Platform, IQVIA, Jane Reed, Head of Life Science Strategy, Linguamatics, an IQVIA company 06.16.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Importance of CAR-T Cell Therapy in Clinical Trials

      The Industry’s Evolving, Maturing Focus
      Panteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20

    • cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.
      Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • 500+ Sites Join Inato’s Industry Marketplace
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • Adare Pharma Solutions Opens New Small-Scale Lab
    • Stevanato Group Launches After-sales Service Offering
    • X-Chem Acquires IntelliSyn and AviSyn
    • Aphena’s $21M Cookeville Expansion Nears Completion
    • BioMed X, Janssen Enter Oral Drug Delivery Alliance
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    MIND and Mediterranean Diets Linked to Later Onset of Parkinson’s Disease
    Kerry Launches Web-Based Tool for Plant-Based Formulation Challenges
    Coatings World

    Latest Breaking News From Coatings World

    Keyland Polymer UV Powder, LLC Launches UVMax Defender
    Scott McLaughlin to Race in PPG Colors During Rookie INDYCAR Season
    Vink Chemicals Offers parmetol PSG
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Butterfly Network Appoints New Leader
    BD Names Chairman of Board
    Interplex Acquires OCP Group
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Adare Pharma Solutions Opens New Small-Scale Lab
    Stevanato Group Launches After-sales Service Offering
    X-Chem Acquires IntelliSyn and AviSyn
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Estée Lauder Companies Announces Game-Changing Sustainability Goals for Travel Retail
    Aura Introduces Customizable Hair Care
    Corpack Creates Custom Packaging for Marlies Möller Hair Care Line
    Happi

    Latest Breaking News From Happi

    Nice-Pak Receives EPA Approval for Disinfectant Wipes
    FDA Takes Major Action on Hand Sanitizers from Mexico
    Symrise Shares 2020 Sales Figures
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Great Lakes Label debuts new website
    Epson partner creates label applicators for pharmaceutical products
    ACTEGA removes chemicals from laminating adhesives
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    American Made Production Equipment for Mask Manufacturers
    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements' Lucent XP-Curved Expandable TLIF Gains FDA Nod
    FDA OKs OrthoSpin's 2nd Gen Robotic, Digital External Fixation System
    Nextremity Solutions Enters Supply Agreement with Fort Wayne Metals
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    North American Semiconductor Equipment Industry Posts December 2020 Billings
    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    PRINTING United Alliance Announces TAGA Presents Virtual Event

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login